A Novel Anti-Kv10.1 Nanobody Fused to Single-Chain TRAIL Enhances Apoptosis Induction in Cancer Cells
Antibody-based therapies hold promise for a safe and efficient treatment of cancer. The identification of target tumor cells through a specific antigen enriched on their surface and the subsequent delivery of the therapeutic agent only to those cells requires, besides the efficacy of the therapeutic...
Saved in:
| Main Authors: | Franziska Hartung (Author), Thomas Krüwel (Author), Xiaoyi Shi (Author), Klaus Pfizenmaier (Author), Roland Kontermann (Author), Patrick Chames (Author), Frauke Alves (Author), Luis A. Pardo (Author) |
|---|---|
| Format: | Book |
| Published: |
Frontiers Media S.A.,
2020-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Superior Treg-Expanding Properties of a Novel Dual-Acting Cytokine Fusion Protein
by: Tanja Padutsch, et al.
Published: (2019) -
Nanobody
Published: (2021) -
Fluorescent membrane potential assay for drug screening on Kv10.1 channel: identification of BL-1249 as a channel activator
by: Mirsha Aseret Gómez-Herrera, et al.
Published: (2023) -
A comprehensive comparison between camelid nanobodies and single chain variable fragments
by: Yasaman Asaadi, et al.
Published: (2021) -
Effective targeting of microglial P2X7 following intracerebroventricular delivery of nanobodies and nanobody-encoding AAVs
by: Carolina Pinto-Espinoza, et al.
Published: (2022)